10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 150 filers reported holding 10X GENOMICS INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,628,797 | +489.4% | 70,045 | +1094.7% | 0.13% | +773.3% |
| Q1 2022 | $446,000 | +33.1% | 5,863 | +160.7% | 0.02% | +25.0% |
| Q4 2021 | $335,000 | +71.8% | 2,249 | +68.1% | 0.01% | +100.0% |
| Q3 2021 | $195,000 | -89.0% | 1,338 | -85.3% | 0.01% | -89.7% |
| Q2 2021 | $1,780,000 | +101.8% | 9,088 | +45.8% | 0.06% | +45.0% |
| Q4 2020 | $882,000 | +3050.0% | 6,232 | +1859.7% | 0.04% | +1233.3% |
| Q2 2020 | $28,000 | -90.8% | 318 | -94.7% | 0.00% | -96.6% |
| Q3 2019 | $304,000 | – | 6,029 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |